Randomized Study on the Efficacy of Standard Versus Low Roxadustat Dose for Anemia in Patients on Peritoneal Dialysis

This publication has 26 references indexed in Scilit:

• Roxadustat (FG-4592)
  Journal of the American Society of Nephrology, 2016
• Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients
  Nephrology Dialysis Transplantation, 2015
• Trends in Anemia Management Practices in Patients Receiving Hemodialysis and Peritoneal Dialysis: A Retrospective Cohort Analysis
  American Journal of Nephrology, 2015
• Anaemia management and mortality risk in chronic kidney disease
  Nature Reviews Nephrology, 2013
• SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials
  Annals of Internal Medicine, 2013
• Mortality Associated with Dose Response of Erythropoiesis-Stimulating Agents in Hemodialysis versus Peritoneal Dialysis Patients
  American Journal of Nephrology, 2012
• Anaemia management with subcutaneous epoetin delta in patients with chronic kidney disease (predialysis, haemodialysis, peritoneal dialysis): results of an open-label, 1-year study
  BMC Nephrology, 2009
• Intestinal Hypoxia-Inducible Transcription Factors Are Essential for Iron Absorption following Iron Deficiency
  Cell Metabolism, 2009
• The prevalence of anemia in patients with chronic kidney disease
  Current Medical Research and Opinion, 2004
• A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
  Journal of Chronic Diseases, 1987